Literature DB >> 26409319

Defective cancellous bone structure and abnormal response to PTH in cortical bone of mice lacking Cx43 cytoplasmic C-terminus domain.

Rafael Pacheco-Costa1, Hannah M Davis2, Chad Sorenson3, Mary C Hon4, Iraj Hassan5, Rejane D Reginato6, Matthew R Allen7, Teresita Bellido8, Lilian I Plotkin9.   

Abstract

Connexin 43 (Cx43) forms gap junction channels and hemichannels that allow the communication among osteocytes, osteoblasts, and osteoclasts. Cx43 carboxy-terminal (CT) domain regulates channel opening and intracellular signaling by acting as a scaffold for structural and signaling proteins. To determine the role of Cx43 CT domain in bone, mice in which one allele of full length Cx43 was replaced by a mutant lacking the CT domain (Cx43(ΔCT/fl)) were studied. Cx43(ΔCT/fl) mice exhibit lower cancellous bone volume but higher cortical thickness than Cx43(fl/fl) controls, indicating that the CT domain is involved in normal cancellous bone gain but opposes cortical bone acquisition. Further, Cx43(ΔCT) is able to exert the functions of full length osteocytic Cx43 on cortical bone geometry and mechanical properties, demonstrating that domains other than the CT are responsible for Cx43 function in cortical bone. In addition, parathyroid hormone (PTH) failed to increase endocortical bone formation or energy to failure, a mechanical property that indicates resistance to fracture, in cortical bone in Cx43(ΔCT) mice with or without osteocytic full length Cx43. On the other hand, bone mass and bone formation markers were increased by the hormone in all mouse models, regardless of whether full length or Cx43(ΔCT) were or not expressed. We conclude that Cx43 CT domain is involved in proper bone acquisition; and that Cx43 expression in osteocytes is dispensable for some but not all PTH anabolic actions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; Carboxy-terminal domain; Connexin 43; Osteocyte; PTH

Mesh:

Substances:

Year:  2015        PMID: 26409319      PMCID: PMC4640960          DOI: 10.1016/j.bone.2015.09.011

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  49 in total

1.  Connexin43 interacts with βarrestin: a pre-requisite for osteoblast survival induced by parathyroid hormone.

Authors:  Nicoletta Bivi; Virginia Lezcano; Milena Romanello; Teresita Bellido; Lilian I Plotkin
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

Review 2.  Gap junctions and connexin-interacting proteins.

Authors:  Ben N G Giepmans
Journal:  Cardiovasc Res       Date:  2004-05-01       Impact factor: 10.787

3.  Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice.

Authors:  Gang-Qing Yao; Jian-Jun Wu; Nancy Troiano; Karl Insogna
Journal:  J Bone Miner Metab       Date:  2010-07-03       Impact factor: 2.626

Review 4.  The gap junction cellular internet: connexin hemichannels enter the signalling limelight.

Authors:  W Howard Evans; Elke De Vuyst; Luc Leybaert
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

5.  The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.

Authors:  Kimihiko Sawakami; Alexander G Robling; Minrong Ai; Nathaniel D Pitner; Dawei Liu; Stuart J Warden; Jiliang Li; Peter Maye; David W Rowe; Randall L Duncan; Matthew L Warman; Charles H Turner
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

6.  High bone mass in mice lacking Cx37 because of defective osteoclast differentiation.

Authors:  Rafael Pacheco-Costa; Iraj Hassan; Rejane D Reginato; Hannah M Davis; Angela Bruzzaniti; Matthew R Allen; Lilian I Plotkin
Journal:  J Biol Chem       Date:  2014-02-07       Impact factor: 5.157

7.  Connexin 43 deficiency attenuates loss of trabecular bone and prevents suppression of cortical bone formation during unloading.

Authors:  Shane A Lloyd; Gregory S Lewis; Yue Zhang; Emmanuel M Paul; Henry J Donahue
Journal:  J Bone Miner Res       Date:  2012-11       Impact factor: 6.741

Review 8.  In vitro and in vivo approaches to study osteocyte biology.

Authors:  Ivo Kalajzic; Brya G Matthews; Elena Torreggiani; Marie A Harris; Paola Divieti Pajevic; Stephen E Harris
Journal:  Bone       Date:  2012-10-13       Impact factor: 4.398

9.  Cardiac malformation in neonatal mice lacking connexin43.

Authors:  A G Reaume; P A de Sousa; S Kulkarni; B L Langille; D Zhu; T C Davies; S C Juneja; G M Kidder; J Rossant
Journal:  Science       Date:  1995-03-24       Impact factor: 47.728

10.  Deletion of Cx43 from osteocytes results in defective bone material properties but does not decrease extrinsic strength in cortical bone.

Authors:  Nicoletta Bivi; Mark T Nelson; Meghan E Faillace; Jiliang Li; Lisa M Miller; Lilian I Plotkin
Journal:  Calcif Tissue Int       Date:  2012-08-04       Impact factor: 4.333

View more
  18 in total

1.  Communication of cAMP by connexin43 gap junctions regulates osteoblast signaling and gene expression.

Authors:  Aditi Gupta; Hidayah Anderson; Atum M Buo; Megan C Moorer; Margaret Ren; Joseph P Stains
Journal:  Cell Signal       Date:  2016-05-06       Impact factor: 4.315

2.  Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice.

Authors:  Hannah M Davis; Alyson L Essex; Sinai Valdez; Padmini J Deosthale; Mohammad W Aref; Matthew R Allen; Andrea Bonetto; Lilian I Plotkin
Journal:  Bone       Date:  2019-04-24       Impact factor: 4.398

Review 3.  Osteocytic signalling pathways as therapeutic targets for bone fragility.

Authors:  Lilian I Plotkin; Teresita Bellido
Journal:  Nat Rev Endocrinol       Date:  2016-05-27       Impact factor: 43.330

4.  Reversal of loss of bone mass in old mice treated with mefloquine.

Authors:  Rafael Pacheco-Costa; Hannah M Davis; Emily G Atkinson; Julian E Dilley; Innocent Byiringiro; Mohammad W Aref; Matthew R Allen; Teresita Bellido; Lilian I Plotkin
Journal:  Bone       Date:  2018-06-05       Impact factor: 4.398

5.  Cx43 overexpression in osteocytes prevents osteocyte apoptosis and preserves cortical bone quality in aging mice.

Authors:  Hannah M Davis; Mohammad W Aref; Alexandra Aguilar-Perez; Rafael Pacheco-Costa; Kimberly Allen; Sinai Valdez; Carmen Herrera; Emily G Atkinson; Arwa Mohammad; David Lopez; Marie A Harris; Stephen E Harris; Matthew Allen; Teresita Bellido; Lilian I Plotkin
Journal:  JBMR Plus       Date:  2018-01-18

Review 6.  Connexins and Pannexins in Bone and Skeletal Muscle.

Authors:  Lilian I Plotkin; Hannah M Davis; Bruno A Cisterna; Juan C Sáez
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

Review 7.  Connexin43 and the Intercellular Signaling Network Regulating Skeletal Remodeling.

Authors:  Megan C Moorer; Joseph P Stains
Journal:  Curr Osteoporos Rep       Date:  2017-02       Impact factor: 5.096

Review 8.  Connexins in the skeleton.

Authors:  Joseph P Stains; Roberto Civitelli
Journal:  Semin Cell Dev Biol       Date:  2015-12-29       Impact factor: 7.727

Review 9.  Cortical bone development, maintenance and porosity: genetic alterations in humans and mice influencing chondrocytes, osteoclasts, osteoblasts and osteocytes.

Authors:  Tsuyoshi Isojima; Natalie A Sims
Journal:  Cell Mol Life Sci       Date:  2021-07-01       Impact factor: 9.261

10.  Removing or truncating connexin 43 in murine osteocytes alters cortical geometry, nanoscale morphology, and tissue mechanics in the tibia.

Authors:  Max A Hammond; Alycia G Berman; Rafael Pacheco-Costa; Hannah M Davis; Lilian I Plotkin; Joseph M Wallace
Journal:  Bone       Date:  2016-04-23       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.